myomegalin Inhibitors
Myomegalin inhibitors are a class of compounds designed to target and modulate the function of myomegalin, a large protein associated with the regulation of microtubule organization and dynamics. Myomegalin is primarily involved in the nucleation and stabilization of microtubules, which are essential components of the cell's cytoskeleton. These microtubules play critical roles in processes such as intracellular transport, cell division, and maintaining cellular structure. Myomegalin localizes to key cellular structures, including the Golgi apparatus and centrosomes, where it helps regulate microtubule growth and organization. Inhibitors of myomegalin interfere with its ability to interact with microtubules or other microtubule-associated proteins, disrupting normal cytoskeletal dynamics.
The inhibition of myomegalin can lead to significant alterations in cellular architecture and microtubule-related processes. By targeting myomegalin, inhibitors can disrupt the proper formation and stabilization of microtubules, potentially affecting processes like vesicle trafficking, mitosis, and cell movement. Since microtubules are critical for the spatial organization of cellular components, myomegalin inhibitors can cause a breakdown in the organization of organelles such as the Golgi apparatus and centrosomes, resulting in altered cellular function and reduced efficiency in intracellular transport. These inhibitors are valuable for studying the specific role of myomegalin in microtubule regulation and for understanding the broader impact of cytoskeletal dynamics on cell behavior. Through the use of myomegalin inhibitors, researchers can explore how microtubule networks are organized and how disruptions to these networks affect various cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor could lead to the hyperacetylation of histone proteins, resulting in a tightly packed chromatin structure that may decrease the transcriptional activity of the myomegalin gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By disrupting DNA methylation, this compound could decrease the methyl groups on the myomegalin gene promoter, potentially leading to a reduction in gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor could downregulate protein synthesis pathways, potentially leading to a decrease in the synthesis of myomegalin due to a general reduction in mRNA translation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, this chemical could disrupt the PI3K/AKT pathway, leading to a decrease in the transcriptional levels of genes such as myomegalin that are under the control of this pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
By selectively inhibiting PDE4, rolipram increases intracellular cAMP levels, which could lead to the activation of PKA and subsequent inhibition of transcription factors responsible for myomegalin gene transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
This adenylate cyclase activator could elevate cAMP, potentially leading to a downregulation of myomegalin expression due to feedback inhibition mechanisms within the cAMP signaling pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound could inhibit DNA methyltransferases, potentially leading to hypomethylation of the myomegalin gene promoter and a subsequent decrease in its expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By inhibiting sirtuin enzymes, resveratrol could alter the acetylation status of histones associated with the myomegalin gene, leading to a reduction in its expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
This compound could inhibit the activation of NF-κB, possibly leading to the downregulation of myomegalin expression if NF-κB is a factor in its transcriptional activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This short-chain fatty acid could inhibit histone deacetylation, which may result in chromatin remodeling that decreases accessibility to transcription machinery for the myomegalin gene. | ||||||